Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study

Yohannes Ejigu*, Jeanette H. Magnus, Johanne Sundby, Maria C. Magnus

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

1 Citation (Scopus)
105 Downloads (Pure)

Abstract

OBJECTIVE: The objective of the study was to compare pregnancy outcomes according to maternal antiretroviral treatment (ART) regimens.

DESIGN: A retrospective cohort study.

PARTICIPANTS AND SETTINGS: Clinical data was extracted from ART exposed pregnancies of HIV-infected Ethiopian women attending antenatal care follow-up in public health facilities in Addis Ababa between February 2010 and October 2016.

OUTCOMES: The primary outcomes evaluated were preterm birth, low birth weight and small-for-gestational-age.

RESULTS: A total 1663 of pregnancies exposed to ART were included in the analyses. Of these pregnancies, 17% resulted in a preterm birth, 19% in low birth weight and 32% in a small-for-gestational-age baby. Compared with highly active antiretroviral therapy (HAART) initiated during pregnancy, zidovudine monotherapy was less likely to result in preterm birth (adjusted OR 0.35, 95% CI 0.19 to 0.64) and low birth weight (adjusted OR 0.48, 95% CI 0.24 to 0.94). We observed no differential risk of preterm birth, low birth weight and small-for-gestational-age, when comparing women who initiated HAART during pregnancy to women who initiated HAART before conception. The risk for preterm birth was higher in pregnancies exposed to nevirapine-based HAART (adjusted OR 1.44, 95% CI 1.06 to 1.96) compared with pregnancies exposed to efavirenz-based HAART. Comparing nevirapine-based HAART with efavirenz-based HAART indicated no strong evidence of increased risk of low birth weight or small-for-gestational-age.

CONCLUSIONS: We observed a higher risk of preterm birth among women who initiated HAART during pregnancy compared with zidovudine monotherapy. Pregnancies exposed to nevirapine-based HAART also had a greater risk of preterm births compared with efavirenz-based HAART.

Original languageEnglish
Article numbere027344
Number of pages9
JournalBMJ Open
Volume9
DOIs
Publication statusPublished - 5 Aug 2019

Keywords

  • antiretroviral therapy
  • HIV
  • low birth weight
  • preterm birth
  • small-for-gestational-age

Fingerprint

Dive into the research topics of 'Pregnancy outcome among HIV-infected women on different antiretroviral therapies in Ethiopia: a cohort study'. Together they form a unique fingerprint.

Cite this